|Bid||65.47 x 900|
|Ask||66.10 x 800|
|Day's Range||64.80 - 65.92|
|52 Week Range||63.25 - 89.70|
|Beta (5Y Monthly)||0.62|
|PE Ratio (TTM)||31.49|
|Earnings Date||Jul 28, 2022|
|Forward Dividend & Yield||1.16 (1.76%)|
|Ex-Dividend Date||Jun 02, 2022|
|1y Target Est||86.85|
Subscribe to Yahoo Finance Plus to view Fair Value for BAX
Baxter International Inc. (NYSE: BAX), a global medtech leader, today released its 2021 Corporate Responsibility Report, demonstrating how the company is progressing toward its 2030 Corporate Responsibility Commitment and Goals. The report highlights the continued progress Baxter has made to advance environmental, social and governance (ESG) performance across its operations and philanthropic programs.
The U.S. Food and Drug Administration on Thursday classified the recall of some Baxter International Inc's lung therapy devices as the most serious type after reports of two deaths. Medical device maker Baxter in late April recalled about 268 devices distributed between May 28, 2020 and April 19, 2022. The device, Volara, is used to deliver therapies for several conditions such as for lung complications.
In this article we are going to estimate the intrinsic value of Baxter International Inc. ( NYSE:BAX ) by taking the...